GENXONEGG

GENXONE

6.10PLND
0.000.00%
At close at May 23, 15:58 GMT
PLN
No trades
See on Supercharts

GX1 fundamentals

Key facts

Market capitalization‪20.16 M‬PLN
Basic EPS (TTM)−1.15PLN
Founded2016
CEOMichal Kaszuba
Websitegenxone.eu
About

GenXone SA is a biotechnology company, which engages in the development of products and solutions based on the latest technologies of nucleic acid sequencing. It also offers diagnostic tests. The company was founded by Michal Kaszuba in 2016 and is headquartered in Suchy Las, Poland.

Ownership
‪‪3.30 M‬‬
Free Float shares
‪‪1.74 M‬‬ (52.8%)
Closely held shares
‪‪1.56 M‬‬ (47.2%)
Free Float shares
‪‪1.74 M‬‬ (52.8%)
Closely held shares
‪‪1.56 M‬‬ (47.2%)
Capital structure
Market cap
‪‪20.16 M‬‬
Cash & equivalents
‪‪4.88 M‬‬
Enterprise value
‪‪15.28 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪20.16 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
10.66x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
10.66x
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪3.50‬
‪7.00‬
‪10.50‬
‪14.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−270%‬
‪−240%‬
‪−210%‬
‪−180%‬
‪−150%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−2.10 M‬‬
‪‪−1.40 M‬‬
‪‪−700.00 K‬‬
‪0.00‬
‪‪700.00 K‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−800.00 K‬‬
‪‪−400.00 K‬‬
‪0.00‬
‪‪400.00 K‬‬
‪‪800.00 K‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−800.00 K‬‬
‪‪−400.00 K‬‬
‪0.00‬
‪‪400.00 K‬‬
‪‪800.00 K‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Nucleic Acid Sequencing Services
By country
Period: 2024
Poland
International

Dividends

Dividend yield, history and sustainability

Dividend summary
0.00%
Payout ratio (TTM)
Dividend yield TTM
0.00%
Last payment
Last ex-date
Last pay date
Dividend history
‪0.0%‬
‪1.2%‬
‪2.4%‬
‪3.6%‬
‪4.8%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪1.70 M‬‬
‪‪3.40 M‬‬
‪‪5.10 M‬‬
‪‪6.80 M‬‬
Assets
Liabilities